Drug Science will study the benefits of medical cannabis for patients with Long COVID
New medical cannabis study approved Drug Science is pleased to announce that the UK’s NHS Research Ethics Committee (NHS REC) and Medicines and Healthcare products Regulatory agency (MHRA) has granted our researchers permission to study the effects of medical cannabis on long-COVID. Following this approval, our new patient study will run for six months from …